Interpace Diagnostics Group (IDXG)
OTHER OTC:IDXG
Holding IDXG?
Track your performance easily

Interpace Diagnostics Group (IDXG) Financial Statements

410 Followers

Interpace Diagnostics Group Financial Overview

Interpace Diagnostics Group's market cap is currently ―. The company's EPS TTM is $1.069; its P/E ratio is 2.73; Interpace Diagnostics Group is scheduled to report earnings on March 26, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Sep 23Jun 23
Income Statement-
Total Revenue$ 12.29M$ 12.04M$ 10.27M$ 9.08M$ 11.03M
Gross Profit$ 7.51M$ 7.43M$ 6.07M$ 4.95M$ 6.83M
EBIT$ 1.51M$ 2.32M$ 773.00K$ -524.00K$ 627.00K
EBITDA$ 1.70M$ 2.50M$ 933.00K$ -270.00K$ 1.21M
Net Income Common Stockholders$ 1.28M$ 2.06M$ 468.00K$ -614.00K$ 175.00K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 2.11M$ 2.02M$ 2.81M$ 5.03M$ 5.08M
Total Assets$ 14.04M$ 12.97M$ 12.14M$ 14.25M$ 15.94M
Total Debt$ 6.88M$ 8.07M$ 10.20M$ 13.12M$ 14.45M
Net Debt$ 4.76M$ 6.05M$ 7.39M$ 8.09M$ 9.37M
Total Liabilities$ 25.18M$ 72.00M$ 73.28M$ 30.39M$ 31.61M
Stockholders Equity$ -57.68M$ -59.03M$ -61.14M$ -62.68M$ -62.21M
Cash Flow-
Free Cash Flow$ 1.59M$ 1.21M$ -86.00K$ 953.00K$ 300.00K
Operating Cash Flow$ 2.12M$ 1.40M$ -58.00K$ 1.10M$ 411.00K
Investing Cash Flow$ -522.00K$ -197.00K$ -28.00K$ 348.00K$ -228.00K
Financing Cash Flow$ -1.50M$ -2.00M$ -600.00K$ -1.50M$ -700.00K
Currency in USD

Interpace Diagnostics Group Earnings and Revenue History

Interpace Diagnostics Group Debt to Assets

Interpace Diagnostics Group Cash Flow

Interpace Diagnostics Group Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis